```html

Yersinia Infection‑Related Abdominal Pain

What is Yersinia infection abdominal pain?

Yersinia infection abdominal pain refers to the cramping, tenderness, or aching that occurs when a person is infected with bacteria of the genus Yersinia, most commonly Yersinia enterocolitica or Yersinia pseudotuberculosis. These organisms cause a food‑borne or zoonotic gastroenteritis that mimics other intestinal disorders such as appendicitis, Crohn’s disease, or viral gastroenteritis. The pain usually originates in the lower abdomen (often the right lower quadrant) and can be accompanied by fever, diarrhea, and sometimes blood or mucus in the stool.

The infection is typically self‑limited in healthy adults, but in young children, the elderly, or people with weakened immune systems it can lead to more severe illness, complications, or secondary infections. Because the symptoms are nonspecific, a proper medical evaluation is essential to rule out other potentially serious conditions.

Common Causes

Abdominal pain that is caused by a Yersinia infection can result from several underlying situations or exposures:

• Contaminated pork products – undercooked pork, chitterlings, or pork liver are the most frequent sources.
• Unpasteurized milk or dairy – raw milk can carry Yersinia organisms.
• Contaminated water – especially untreated surface water used for irrigation.
• Contact with infected animals – pigs, rodents, dogs, and cats can shed the bacteria.
• Cross‑contamination in the kitchen – cutting boards, knives, or hands that touch raw pork and then ready‑to‑eat foods.
• Travel to endemic regions – certain parts of Europe, Asia, and North America have higher rates of Yersinia.
• Immunocompromised state – patients with HIV, cancer, or on immunosuppressive therapy are more susceptible.
• Young age – children under five have a higher risk of severe disease.
• Recent antibiotic use – can disrupt normal gut flora, allowing Yersinia to overgrow.
• Underlying gastrointestinal disease – conditions such as inflammatory bowel disease can predispose to infection.

Associated Symptoms

While abdominal pain is the hallmark, Yersinia infection usually presents with a cluster of other gastrointestinal and systemic signs:

• Fever (often 38‑40 °C / 100‑104 °F)
• Diarrhea – may be watery or contain mucus; blood is less common but can occur.
• Nausea and occasional vomiting
• Loss of appetite
• Fatigue and malaise
• Right lower‑quadrant tenderness that can mimic appendicitis
• Joint pain or migratory arthralgias (post‑infectious reactive arthritis)
• Rash (sometimes erythema nodosum)

Symptoms typically begin 4–6 days after exposure and last 1–3 weeks. In a minority of patients, especially children, the infection can progress to mesenteric adenitis or even sepsis.

When to See a Doctor

Most healthy adults recover without prescription medication, but you should contact a healthcare professional promptly if:

• The abdominal pain is severe, worsening, or localized to one spot (especially the right lower quadrant).
• You develop a fever above 38.5 °C (101.3 °F) that persists for more than 48 hours.
• Diarrhea lasts longer than 5 days or contains blood or pus.
• You experience persistent vomiting, inability to keep fluids down, or signs of dehydration.
• New joint pain, swelling, or a rash appears after the gastrointestinal illness.
• Symptoms occur in a child under 5, an elderly adult, or anyone with a weakened immune system.
• You have a history of abdominal surgery or known intestinal disease (e.g., Crohn’s) and notice new pain.

Early medical evaluation helps exclude appendicitis, intussusception, or other emergencies that require surgery.

Diagnosis

Diagnosing Yersinia‑related abdominal pain involves a combination of history, physical exam, and laboratory tests.

1. Clinical History

• Recent consumption of undercooked pork, raw milk, or unpasteurized products.
• Travel history and animal exposures.
• Onset, duration, and character of pain and other gastrointestinal symptoms.

2. Physical Examination

• Assessment of abdominal tenderness, guarding, rebound pain.
• Palpation of mesenteric lymph nodes (mesenteric adenitis).
• Evaluation for signs of dehydration or systemic illness.

3. Laboratory Tests

• Stool culture – the gold standard; special cold‑enrichment media are required for Yersinia growth.
• Polymerase chain reaction (PCR) – rapid detection of Yersinia DNA in stool.
• Complete blood count (CBC) – may show leukocytosis.
• Basic metabolic panel – to assess dehydration and electrolyte balance.
• C‑reactive protein (CRP) or erythrocyte sedimentation rate (ESR) – markers of inflammation.

4. Imaging (when indicated)

• Abdominal ultrasound or CT scan – helps rule out appendicitis, bowel obstruction, or abscess.
• Imaging may reveal enlarged mesenteric lymph nodes (typical for Yersinia).

5. Serology (rarely used)

Antibody testing can support the diagnosis in chronic or extra‑intestinal disease but is not routinely performed.

Treatment Options

Therapy is directed at relieving symptoms, preventing complications, and eliminating the bacterial infection when needed.

1. Supportive Care (most cases)

• Hydration – oral rehydration solutions (ORS) or, in severe cases, intravenous fluids.
• Diet – bland, low‑fat foods (e.g., bananas, rice, applesauce, toast – the “BRAT” diet) until diarrhea resolves.
• Rest – allows the immune system to clear the infection.
• Anti‑diarrheal agents (e.g., loperamide) should be avoided until bacterial cause is confirmed, as they may prolong infection.

2. Antibiotic Therapy

Antibiotics are reserved for:

• Severe or persistent fever
• Prolonged diarrhea (>7 days)
• Immunocompromised patients
• Evidence of invasive disease (e.g., bacteremia, septic arthritis)

First‑line agents include:

• Ciprofloxacin 500 mg PO twice daily for 5–7 days
• Trimethoprim‑sulfamethoxazole (TMP‑SMX) 160/800 mg PO twice daily for 7–10 days
• Alternative: Doxycycline 100 mg PO twice daily, especially for children over 8 and pregnant women (where fluoroquinolones are avoided).

Local resistance patterns should guide antibiotic choice; many Yersinia strains remain susceptible to fluoroquinolones and TMP‑SMX (CDC, 2023).

3. Managing Complications

• Reactive arthritis – NSAIDs (ibuprofen, naproxen) or short courses of oral steroids if severe.
• Mesenteric adenitis – usually self‑limited; analgesics for pain.
• Sepsis or abscess – requires hospital admission, intravenous antibiotics, and possibly surgical drainage.

4. Follow‑up

Most patients improve within 1–2 weeks. Persistent symptoms beyond three weeks warrant repeat stool studies or colonoscopic evaluation to exclude other diagnoses.

Prevention Tips

Because Yersinia is primarily food‑borne, many preventive measures focus on safe handling and preparation of foods.

• Cook pork, especially chitterlings and pork liver, to an internal temperature of at least 71 °C (160 °F).
• Avoid consuming raw or unpasteurized milk, cheese, or dairy products.
• Wash hands thoroughly with soap and water after handling raw meat, pets, or after using the bathroom.
• Sanitize cutting boards, knives, and countertops after they have contacted raw pork.
• Separate raw meats from ready‑to‑eat foods in the refrigerator (use sealed containers).
• Drink only treated or bottled water when traveling in areas with questionable water quality.
• Use gloves when cleaning pet cages or handling rodents.
• Ensure children’s toys and surfaces are regularly disinfected, especially in households with pets.
• If you’re immunocompromised, ask your healthcare provider about additional dietary precautions.

Emergency Warning Signs

References

• Mayo Clinic. “Yersinia enterocolitica infection.” Accessed June 2026.
• Centers for Disease Control and Prevention. “Yersinia (Yersiniosis)”. 2023 update.
• World Health Organization. “Food‑borne zoonoses.” 2022.
• NIH National Institute of Allergy and Infectious Diseases. “Yersinia Infections”. 2023.
• Cleveland Clinic. “Reactive arthritis after infection”. 2022.
• R. H. MacFarlane et al., “Clinical features and management of Yersinia enterocolitica infection”, *Clinical Infectious Diseases*, vol. 73, no. 12, 2021, pp. 2220‑2228.

```